NIAID Banner Logo Image

HIV Citation List: May 10 - May 23, 2013

PubMed citations

1. Novel Inhibitors of SARS-CoV Entry Acting by Three Distinct Mechanisms. Adedeji, A.O., W. Severson, C. Jonsson, K. Singh, S.R. Weiss, and S.G. Sarafianos. Journal of Virology, 2013. [Epub ahead of print]. PMID[23678171].
[PubMed]. HIV_0510-052313.


2. Bifunctional Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Mechanism and Proof-of-concept as a Novel Therapeutic Design Strategy. Bailey, C.M., T.J. Sullivan, P. Iyidogan, J. Tirado-Rives, R. Chung, J. Ruiz-Caro, E. Mohamed, W. Jorgensen, R. Hunter, and K.S. Anderson. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23659183].
[PubMed]. HIV_0510-052313.


3. Sulfation and Biological Activities of Konjac Glucomannan. Bo, S., T. Muschin, T. Kanamoto, H. Nakashima, and T. Yoshida. Carbohydrate Polymers, 2013. 94(2): p. 899-903. PMID[23544648].
[PubMed]. HIV_0510-052313.


4. Characterization of Antiviral Activity of a Benzamide Derivative AH0109 against HIV-1 Infection. Chen, L., Z. Ao, K. Danappa Jayappa, G. Kobinger, S. Liu, G. Wu, M.A. Wainberg, and X. Yao. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23669388].
[PubMed]. HIV_0510-052313.


5. Benzofuran Derivatives: A Patent Review. Dawood, K.M. Expert Opinion on Therapeutic Patents, 2013. [Epub ahead of print]. PMID[23683135].
[PubMed]. HIV_0510-052313.


6. Novel Inhibitor Binding Site Discovery on HIV-1 Capsid N-terminal Domain by NMR and X-ray Crystallography. Goudreau, N., C.T. Lemke, A.M. Faucher, C. Grand-Maitre, S. Goulet, J.E. Lacoste, J. Rancourt, E. Malenfant, J.F. Mercier, S. Titolo, and S.W. Mason. ACS Chemical Biology, 2013. 8(5): p. 1074-1082. PMID[23496828].
[PubMed]. HIV_0510-052313.


7. Inhibition of HIV Replication in Vitro by Clinical Immunosuppressants and Chemotherapeutic Agents. Hawley, T., M. Spear, J. Guo, and Y. Wu. Cell & Bioscience, 2013. 3(1): p. 22. PMID[23672887].
[PubMed]. HIV_0510-052313.


8. Mice Transgenic for CD4-Specific Human CD4, CCR5 and Cyclin T1 Expression: A New Model for Investigating HIV-1 Transmission and Treatment Efficacy. Seay, K., X. Qi, J.H. Zheng, C. Zhang, K. Chen, M. Dutta, K. Deneroff, C. Ochsenbauer, J.C. Kappes, D.R. Littman, and H. Goldstein. PloS One, 2013. 8(5): p. e63537. PMID[23691059].
[PubMed]. HIV_0510-052313.


9. HIV-1 Resistance Mechanism to an Electrostatically Constrained Peptide Fusion Inhibitor That Is Active against T-20-resistant Strains. Shimane, K., K. Kawaji, F. Miyamoto, S. Oishi, K. Watanabe, Y. Sakagami, N. Fujii, K. Shimura, M. Matsuoka, M. Kaku, S.G. Sarafianos, and E.N. Kodama. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23689710].
[PubMed]. HIV_0510-052313.


10. Design, Synthesis and Biological Evaluation of Novel 3,5-Disubstituted-1,2,6-thiadiazine-1,1-dione Derivatives as HIV-1 NNRTIs. Tian, Y., D. Rai, P. Zhan, C. Pannecouque, J. Balzarini, E. De Clercq, H. Liu, and X. Liu. Chemical Biology & Drug Design, 2013. [Epub ahead of print]. PMID[23659687].
[PubMed]. HIV_0510-052313.


11. A Combined 3D-QSAR and Docking Studies for the in-Silico Prediction of HIV-protease Inhibitors. Ul-Haq, Z., S. Usmani, H. Shamshad, U. Mahmood, and S.A. Halim. Chemistry Central Journal, 2013. 7(1): p. 88. PMID[23683267].
[PubMed]. HIV_0510-052313.


12. A Synthetic Bivalent Ligand of CXCR4 Inhibits HIV Infection. Xu, Y., S. Duggineni, S. Espitia, D.D. Richman, J. An, and Z. Huang. Biochemical and Biophysical Research Communications, 2013. [Epub ahead of print]. PMID[23688427].
[PubMed]. HIV_0510-052313.

ISI Web of Knowledge Citations

13. Nephrotoxicity of Antiretroviral Agents: Is the List Getting Longer? Fine, D.M. and J.E. Gallant. Journal of Infectious Diseases, 2013. 207(9): p. 1349-1351. ISI[000317434600001].
[WOS]. HIV_0510-052313.


14. Study of Addition of Difluorocarbene on Double Bond of Triterpenes. Biedermann, D., M. Urban, M. Budesinsky, M. Kvasnica, and J. Sarek. Journal of Fluorine Chemistry, 2013. 148: p. 30-35. ISI[000317446800005].
[WOS]. HIV_0510-052313.


15. New Triterpenoids from the Fruits of Schisandra wilsoniana and Their Biological Activities. Gao, X.M., Y.Q. Li, L.D. Shu, Y.Q. Shen, L.Y. Yang, L.M. Yang, Y.T. Zheng, H.D. Sun, W.L. Xiao, and Q.F. Hu. Bulletin of the Korean Chemical Society, 2013. 34(3): p. 827-830. ISI[000317168200026].
[WOS]. HIV_0510-052313.


16. Gelsolin Activity Controls Efficient Early HIV-1 Infection. Garcia-Exposito, L., S. Ziglio, J. Barroso-Gonzalez, L. de Armas-Rillo, M.S. Valera, D. Zipeto, J.D. Machado, and A. Valenzuela-Fernandez. Retrovirology, 2013. 10. ISI[000317733400001].
[WOS]. HIV_0510-052313.


17. Synthesis, Biological Evaluation, and Molecular Modeling Studies of New 1,3,4-Oxadiazole- and 1,3,4-Thiadiazole-substituted 4-oxo-4H-pyrido[1,2-a]pyrimidines as anti-HIV-1 Agents. Hajimahdi, Z., A. Zarghi, R. Zabihollahi, and M.R. Aghasadeghi. Medicinal Chemistry Research, 2013. 22(5): p. 2467-2475. ISI[000316912800043].
[WOS]. HIV_0510-052313.


18. Mechanism of Resistance to S138A Substituted Enfuvirtide and Its Application to Peptide Design. Izumi, K., K. Kawaji, F. Miyamoto, K. Shimane, K. Shimura, Y. Sakagami, T. Hattori, K. Watanabe, S. Oishi, N. Fujii, M. Matsuoka, M. Kaku, S.G. Sarafianos, and E.N. Kodama. International Journal of Biochemistry & Cell Biology, 2013. 45(4): p. 908-915. ISI[000317371300017].
[WOS]. HIV_0510-052313.


20. Structural and Functional Role of INI1 and LEDGF in the HIV-1 Preintegration Complex. Maillot, B., N. Levy, S. Eiler, C. Crucifix, F. Granger, L. Richert, P. Didier, J. Godet, K. Pradeau-Aubreton, S. Emiliani, A. Nazabal, P. Lesbats, V. Parissi, Y. Mely, D. Moras, P. Schultz, and M. Ruff. PloS One, 2013. 8(4). ISI[000317383200018].
[WOS]. HIV_0510-052313.


21. Oligo(2'-O-methylribonucleotides) and Their Derivatives: IV. Conjugates of Oligo(2'-O-methylribonucleotides) with Minor Groove Binders and Intercalators: Synthesis, Properties, and Application. Novopashina, D.S., A.N. Sinyakov, V.A. Ryabinin, L. Perrouault, C. Giovannangeli, A.G. Venyaminova, and A.S. Boutorine. Russian Journal of Bioorganic Chemistry, 2013. 39(2): p. 138-152. ISI[000316686600004].
[WOS]. HIV_0510-052313.


22. Chemoselective Synthesis of N-substituted alpha-Amino-alpha '-chloro Ketones Via Chloromethylation of Glycine-derived Weinreb Amides. Pace, V., W. Holzer, G. Verniest, A.R. Alcantara, and N. De Kimpe. Advanced Synthesis & Catalysis, 2013. 355(5): p. 919-926. ISI[000316808200016].
[WOS]. HIV_0510-052313.


23. Histone Deacetylase Inhibitor MC1293 Induces Latent HIV-1 Reactivation by Histone Modification in Vitro Latency Cell Lines. Qu, X.Y., H. Ying, X.H. Wang, C.J. Kong, X. Zhou, P.F. Wang, and H.Z. Zhu. Current HIV Research, 2013. 11(1): p. 24-29. ISI[000317098100004].
[WOS]. HIV_0510-052313.


23. Piperidin-4-one: The Potential Pharmacophore. Sahu, S.K., B.K. Dubey, A.C. Tripathi, M. Koshy, and S.K. Saraf. Mini-reviews in Medicinal Chemistry, 2013. 13(4): p. 565-583. ISI[000317209300009].
[WOS]. HIV_0510-052313.


24. Synthesis, Properties, and anti-HIV Activity of New Lipophilic 3'-Azido-3'-deoxythymidine Conjugates Containing Functional Phosphoric Linkages. Shastina, N.S., T.Y. Maltseva, L.N. D'Yakova, O.A. Lobach, M.S. Chataeva, D.N. Nosik, and V.I. Shvetz. Russian Journal of Bioorganic Chemistry, 2013. 39(2): p. 161-169. ISI[000316686600006].
[WOS]. HIV_0510-052313.


25. Synthesis of Novel 2'-Spirocyclopropanoid 4'-deoxythreosyl phosphonic acid Nucleoside Analogues. Shen, G.H. and J.H. Hong. Bulletin of the Korean Chemical Society, 2013. 34(3): p. 868-874. ISI[000317168200032].
[WOS]. HIV_0510-052313.


26. Polyoxometalates as Versatile Enzyme Inhibitors. Stephan, H., M. Kubeil, F. Emmerling, and C.E. Muller. European Journal of Inorganic Chemistry, 2013(10-11): p. 1585-1594. ISI[000316912500005].
[WOS]. HIV_0510-052313.


27. Synthesis and Biological Activity of Mono- and Diamides of 2,3-Secotriterpene acids. Tolmacheva, I.A., E.V. Igosheva, Y.B. Vikharev, V.V. Grishko, O.V. Savinova, E.I. Boreko, and V.F. Eremin. Russian Journal of Bioorganic Chemistry, 2013. 39(2): p. 186-193. ISI[000316686600010].
[WOS]. HIV_0510-052313.


28. Potential of the Novel Antiretroviral Drug Rilpivirine to Modulate the Expression and Function of Drug Transporters and Drug-metabolising Enzymes in Vitro. Weiss, J. and W.E. Haefeli. International Journal of Antimicrobial Agents, 2013. 41(5): p. 484-487. ISI[000317743200016].
[WOS]. HIV_0510-052313.


29. Synthesis and Biological Evaluation of Novel Hydroxylphenethyl-S-DACOs as High Active anti-HIV Agents. Wu, D.C., D.M. Zhuang, X.F. Liu, L.H. Lu, H. Wang, C. Li, C.C. Lai, J.Y. Li, and Y.P. He. Letters in Drug Design & Discovery, 2013. 10(3): p. 271-276. ISI[000317926100010].
[WOS]. HIV_0510-052313.


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2022